journal article·2021-08

Site‐Specific Biomimicry of Antioxidative Melanin Formation and Its Application for Acute Liver Injury Therapy and Imaging

Caiyan Zhao, Zhi Li, Jingxiao Chen, Lichao Su, Junqing Wang, Dean Shuailin Chen, Jiamin Ye, Naishun Liao, Huanghao Yang, Jibin Song, Jinjun Shi

Advanced Materials· Volume 33· Issue 34
Publisher page

Abstract

Abstract Biocompatible nano‐antioxidants composed of natural molecules/materials, such as dopamine and melanin, are of great interest for diverse biomedical applications. However, the lack of understanding of the precise structure of these biomaterials and thus the actual dose of effective components impedes their advancement to translation. Herein, a strategy to mimic in situ melanin formation and explore its antioxidative applications is reported, by developing a PEGylated, phenylboronic‐acid‐protected L‐DOPA precursor (PAD) that can self‐assemble into well‐defined nanoparticles (PADN). Exposure to oxidative species leads to deprotection of phenylboronic acids, transforming PADN to PEG‐L‐DOPA, which, similar to the biosynthetic pathway of melanin, can be oxidized and polymerized into an antioxidative melanin‐like structure. With ultrahigh stability and superior antioxidative activity, the PADN shows remarkable efficacy in prevention and treatment of acute liver injury/failure. Moreover, the in situ structure transformation enables PADN to visualize damaged tissue noninvasively by photoacoustic imaging. Overall, a bioinspired antioxidant with precise structure and site‐specific biological activity for theranostics of oxidative stress‐related diseases is described.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

MOE Key Laboratory for Analytical Science of Food Safety and Biology College of Chemistry, Fujian Science & Technology Innovation Laboratory for Optoelectronic Information of China Fuzhou University Fuzhou 350108 China

Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA

Key Laboratory of Carbohydrate Chemistry and Biotechnology Ministry of Education School of Pharmaceutical Sciences Jiangnan University Wuxi 214122 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Fujian Province

References (58)

Show source-provided references
1. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
2. 10.1038/3504168710.1038/35041687 ↗
3. 10.1038/nchembio.60710.1038/nchembio.607 ↗
4. 10.3390/cells712027410.3390/cells7120274 ↗
5. 10.1002/adma.20190295610.1002/adma.201902956 ↗
6. 10.1038/nrd400210.1038/nrd4002 ↗
7. 10.1155/2017/585323810.1155/2017/5853238 ↗
8. 10.1039/C8CS00718G10.1039/C8CS00718G ↗
9. 10.1007/s12274-018-2092-y10.1007/s12274-018-2092-y ↗
10. 10.1016/j.nantod.2019.05.00810.1016/j.nantod.2019.05.008 ↗
11. 10.1021/acs.nanolett.9b0503510.1021/acs.nanolett.9b05035 ↗
12. 10.1126/sciadv.abb269510.1126/sciadv.abb2695 ↗
13. 10.1002/adma.20150389310.1002/adma.201503893 ↗
14. 10.1002/anie.20171246910.1002/anie.201712469 ↗
15. 10.1039/C1CS15188F10.1039/C1CS15188F ↗
16. 10.1038/s41565-018-0356-z10.1038/s41565-018-0356-z ↗
17. 10.1002/anie.20160252510.1002/anie.201602525 ↗
18. 10.1002/adfm.20180212710.1002/adfm.201802127 ↗
19. 10.1021/jacs.6b1101310.1021/jacs.6b11013 ↗
20. 10.1002/adfm.20190483310.1002/adfm.201904833 ↗
21. 10.1002/adma.20200351110.1002/adma.202003511 ↗
22. 10.1002/adma.20110443710.1002/adma.201104437 ↗
23. 10.1021/cr400407a10.1021/cr400407a ↗
24. 10.1021/ja505412p10.1021/ja505412p ↗
25. 10.1021/acsnano.6b0595110.1021/acsnano.6b05951 ↗
26. 10.1021/la204831b10.1021/la204831b ↗
27. 10.1021/la402028810.1021/la4020288 ↗
28. 10.1021/acsami.7b1986510.1021/acsami.7b19865 ↗
29. 10.1021/jacs.0c1232210.1021/jacs.0c12322 ↗
30. 10.3390/nano1011227610.3390/nano10112276 ↗
31. 10.1021/acs.biomac.9b0141310.1021/acs.biomac.9b01413 ↗
32. 10.1016/j.isci.2019.10077810.1016/j.isci.2019.100778 ↗
33. 10.1021/acsnano.9b0398210.1021/acsnano.9b03982 ↗
34. 10.1002/adma.20130303210.1002/adma.201303032 ↗
35. 10.1002/adfm.20120115610.1002/adfm.201201156 ↗
36. 10.1002/anie.20080378610.1002/anie.200803786 ↗
37. 10.1016/S0040-4020(97)00494-810.1016/S0040-4020(97)00494-8 ↗
38. 10.1002/adma.20120468310.1002/adma.201204683 ↗
39. 10.1021/jp804248h10.1021/jp804248h ↗
40. 10.1021/acscentsci.6b0023010.1021/acscentsci.6b00230 ↗
41. 10.3389/fnut.2018.0008710.3389/fnut.2018.00087 ↗
42. 10.1021/ja002455u10.1021/ja002455u ↗
43. 10.1126/scitranslmed.aan368210.1126/scitranslmed.aan3682 ↗
44. 10.1126/sciadv.aaw892210.1126/sciadv.aaw8922 ↗
45. 10.1002/adma.20170369310.1002/adma.201703693 ↗
46. 10.1126/science.121621010.1126/science.1216210 ↗
47. 10.1038/s41467-019-09034-y10.1038/s41467-019-09034-y ↗
48. 10.2478/v10039-012-0063-110.2478/v10039-012-0063-1 ↗
49. Samarghandian S. · Int. J. Clin. Exp. Med. · 2014 · 7 · 1449
50. 10.1038/nbt.283810.1038/nbt.2838 ↗
51. 10.1016/j.biomaterials.2017.08.00810.1016/j.biomaterials.2017.08.008 ↗
52. 10.1155/2014/46381510.1155/2014/463815 ↗
53. 10.1016/j.nantod.2020.10092510.1016/j.nantod.2020.100925 ↗
54. 10.1038/s41563-019-0462-910.1038/s41563-019-0462-9 ↗
55. 10.1021/acs.nanolett.8b0249810.1021/acs.nanolett.8b02498 ↗
56. 10.1038/s41467-020-16544-710.1038/s41467-020-16544-7 ↗
57. 10.1021/acs.molpharmaceut.7b0040510.1021/acs.molpharmaceut.7b00405 ↗
58. 10.1021/nn506408v10.1021/nn506408v ↗